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INTRODUCTION 
Exfoliative cytology is the microscopic examination of shed or 
desquamated cells from the epithelial surface usually the mucous 
membrane. It also includes the study of those cells that have been 
collected by scraping the tissue surface or collected from body fluids 
such as sputum. 
The understanding and application of exfoliative cytology techniques in 
mucocutaneous malignancies in India is not widely used particularly, for the 
purpose of diagnosis unlike our counter parts in the developed countries. 
More papers on exfoliative cytology were published during the period 1955-
75 than in any other period. Renewed interest emerged in the past decade 
after the employment of newer techniques of quantitative analysis, DNA 
cytomorphometry, and identification of tumour markers on the cytological 
samples.  
 The Rationale of exfoliative cytology lies in the epithelial physiology. 
Continuous exfoliation of epithelial cells is a part of physiological turnover. 
Deeper cells, which are strongly adhered in normal conditions, become loose 
in the case of malignancy and exfoliate along with superficial cells. 
 
The available literature suggests that Walsh was the first person to have 
described cancer cells in a patient's sputum as early as in 1843. 
Lebert in 1851 emphasized the altered size of cells and nuclei as a basis of 
diagnosing cancer. Bealem 1960 attempted a cytological diagnosis of 
oropharyngeal cancer. Dudgeon in1927 devised a direct smear technique of 
surgical specimen for rapid diagnosis. 
 
In the year l941  George N Papanicolaou started using what is today called 
as "PAP test" as a routine procedure for early detection of cervical cancer. 
Ziskin was the first person to have reported the use of exfoliative cytology in 
oral cavity. Montgomery and Von Hamm in1951 used exfoliative cytology 
for the diagnosis of oral cancer. 
John K Frost opines that general biological activity is reflected best in 
nucleus and functional activity is reflected in cytoplasm.  . 
The basic biological feature of a cell whether be it a proplastic (Cell with an 
increased activity) or a retroplastic (a degenerating cell) is defined by the 
chromatin-para chromatin interface. Here the chromatin refers to the 
condensed, functionally inactive heterochromatin seen in the periphery of a 
nucleus and parachromatin refers to the distended functionally active 
chromatin. 
The junction is crisp and sharply defined in proplasia as euchromatin is 
highly active thereby pushing the heterochromatin to the periphery. In 
retroplasia the junction is blurred and indistinct. Proplasia and retroplasia 
can be together considered as euplasia or, the normal cell growth. In contrast 
to a euplastic cell, the morphology of a neoplastic cell is not well defined 
and exhibits protean feature. 
Scrape cytology   forms a reliable outpatient procedure for screening as well 
as for diagnosing mucocutaneous cancer. Moreover scrape cytology can be 
repeated and the patient compliance is excellent. 
Scrape can be done in outpatient settings for rapid diagnosis as against 
biopsy. The duration of the scrape cytology process takes 20 min as against 
3 to 4 days for biopsy.  
Positive results can be taken reliably for making a clinical decision but for 
negative result needs a biopsy for reconfirmation. The sensitivity and 
specificity of the scrape cytology is approaching 100% by applying recent 
advances in various studies. 
 
In the present study we compared the scrape cytology against the gold 
standard biopsy procedu 
re and its reliability in making a clinical decision.   
                                       AIM OF STUDY 
Scrape (exfoliative) cytology is a simple and non invasive procedure, which 
has been a controversial technique according to its real validity. In recent 
times it has re-emerged due to its application in mucocutaneous cancer as a 
diagnostic and predictive method as well as for monitoring patients. New 
diagnostic techniques have been developed, such as “brush biopsy” and 
multiple molecular studies using the cells collected. 
The aim of the present study is to compare the usefulness of scrape cytology 
and biopsy in the diagnosis of accessible mucocutaneous malignancies done 
at Surgical Oncology department of Government Royapettah hospital and 
there by determining its sensitivity, specificity, positive and negative 
predictive value. 
 
    
 
 
 
 
 
  
REVIEW OF LITERATURE: 
 
CYTOPATHOLOGY 
 
Pioneers of cytologic methods made observation that holds true today: the 
power of cytopathology lies in its simplicity. Diagnoses can be made by the 
study of spontaneously exfoliated cells as obtained from the uterine cervix, 
lung or urinary tract, cells that are mechanically dislodged by scraping, 
washing, or brushing.    
 
In the western world, microscopic examination of tissues had become 
established as the standard for cancer diagnosis. 
 
Cytopathology has moved to centre stage in contemporary anatomic 
pathology. Here it occupies two distinctly different roles, serving either as a 
screening test, and it has had unparalleled success in the detection of cellular 
abnormalities of the cervix before they progressed to invasive carcinoma.  
 
Since the late 1940’s ,the incidence and mortality for invasive 
carcinoma of  the  cervix have declined 70%-75% in the U.S. the widespread 
use of the Papanicolaou smear is generally cited has the major factor 
influencing these trends. A philosophy held by most cytopathologist is that a 
cytopathologic diagnosis should carry the same level accuracy as a 
histopathologic diagnosis. With these view, because surgery or chemo 
theraphy may result from the cytopathologic diagnosis, it is paramount that 
the pathologist understand the morphologic criteria that distinguish benign 
from malignant conditions. 
 
Exfoliative cytology has been used as a diagnostic test for precancerous and 
cancerous lesions presenting in the oral cavity' However, in general, 
cytology has relied primarily on the personal judgement of the cytologist. 
The major value of cytology is the non-invasive nature of a simple and 
relatively pain free procedure, which can provide intact cells from different 
layers within the epithelium.  
 
Cytology has been recommended for the early diagnosis of oral cancer and 
proved to be a reliable primary diagnostic test. The aims of this study were 
to apply the quantitative techniques, outlined by Cowpe et al, to smears 
collected from suspicious lesions presenting in the oral cavity.  
 
Thus attempting to improve the diagnostic sensitivity of cytology in the 
detection of early oral malignancy, above and beyond subjective 
interpretation. 
 
PRINCIPLES OF CYTOMORPHOLOGY 
 
For the purposes of diagnostic cytopathology, cells can be categorized 
morphologically in to 5 groups: normal, reactive, degenerate, dysplastic, and 
neoplastic. 
 
 The Assessment of the individual cells is based several parameters, such as 
cell size, cell shape, the ratio of nuclear area to cytoplasmic area, 
cytoplasmic qualities, such as staining or the presence or absence  of mucin, 
nuclear qualities including the size, shape and distribution of chromatin and 
the number, size, shape of the nucleoli. The statements that follow refer to 
cells stained by the Papanicolaou method, which is preferred by most 
American pathologist, because it provides an excellent rendition of nuclear 
morphology and differential staining of the cytoplasm.  
 
In the general evaluation of the cell, there are three broad principles 1. 
morphologic features of the nucleus are most critical to discriminate benign 
cells from malignant cells, 2. cytoplasmic features generally provide clues 
that are suggestive of the manner of cell differentiation (such as squamous 
versus glandular), and 3. a cytologic diagnosis almost always requires the 
consideration of multiple morphologic features for proper classification of 
cells. A Corollary to this last statement is that the diagnosis of malignancy 
always requires the consideration of multiple features. No single cytologic 
feature is diagnostic of malignancy.  
 
NORMAL CELL 
 
 It is evident that the appearances of normal cells differ enormously 
according to the origin. The amount of cytoplasm may be scanty, or it may 
be abundant. Frost, when describing the normal cells, stresses the principles 
of roundness, uniformity, and predictability. The location of nuclei in cells is 
of some diagnostic importance. Nuclear chromatin is typically evenly 
dispersed. In normal cells this membrane is uniform in thickness. 
 
 
 
REACTIVE CELLS 
 
Benign cells may reflect responses to many different external stimuli by 
profound changes in the morphology. The resultant cell forms have been 
called by various names including reactive cells, irritated cells, hyperplastic 
cells, hypertrophic cells, and proplastic cells. 
 
THE DEGENERATE CELLS 
 
 Although cell degeneration and death are normal at the end of a cell’s life 
span, they may also be an inductor of injury. Cell degeneration is significant 
to the cytopathologist because of its potential to be misinterpreted as 
malignancy. During degeneration the nucleus may become swollen and 
portions of the cytoplasm lost. 
 
THE DYSPLASTIC CELL: 
 
Cells in a state of gradual transition from normalcy to frank malignancy 
were described as “dyskaryotic“. Their nuclei were characterized by 
increasing nuclear enlargement, uniform coarsening and hyperchromasia of 
the chromatin, and thickening of the nuclear membrane. Their cytoplasam 
exhibited and increasing failure to mature and differentiate. The term 
dysplasia as applied to these dyskaryotic cells exfoliating from lesion of the 
uterine cervix was introduced by Reagan in 1953. 
 
 
THE NEOPLASTIC CELL 
 
The interpretation of a cell as malignant is a statement by the cytopathologist 
that the cell has the biologic ability to invade tissues and metastasize. It was 
started earlier in this chapter that no single morphologic feature allows 
prediction of malignancy. This concept can not be over emphasized because 
grievous diagnostic error occurs when this simple concept is ignored. Major 
criteria for malignancy are summarized in the cytology feature that define a 
cell as malignant are found principally with in the nucleus. The malignant 
nuclei are abnormally enlarged and often highly variable among a 
population of cells they may show extreme abnormalities of nuclear shape, 
with sharp angulations and deep divot holes or folding of the nuclear 
membrane. This membrane which is uniform in benign cells can be variably 
thick and thin in the malignant nucleus.  
EXFOLIATION                  
 
Spontaneously exfoliated cells are the mainstay of cytologic diagnosis, 
principally because of their ease of collection. Among the earliest 
demonstrations of the cytologic method were the diagnoses of lung cancer in 
cells exfoliated into sputum. Similarly, the cervical papanicolaou smear 
depends on cell exfoliation, albeit with the gentle coaxing by brush or 
spatula. 
 
ADVANTAGES 
1. It is a painless, bloodless, non-invasive, quick and simple procedure.  
2. Suitable in patients with advance disease with poor general condition 
3. Guards against false negative biopsy.  
4. Post biopsy complications can be eliminated. 
 DISADVANTAGES 
1. Relatively less information when compared to a histological slide.  
2. Positive results are reliable but negative are not.  
3. Suitable only for epithelial tissues or for tissues exfoliating cells into 
reasonably accessible sites.  
4. It is only an adjuvant and not a substitute for a biopsy.  
5. Interpretation requires a skilled cytopathologist.  
False positivity is a common draw back for exfoliative cytology, but is it 
imminent''. Answer is a big no. The reason in a majority of false positive 
cases lies in the users and not with the science. A false positive case may be 
due to "early minimal degenerative changes" resulting from processing 
artifacts like improper fixation or air drying causing "cell bleeding" and an 
increased N/C ratio and nuclear wrinkling. So, if the technique is good the 
results are always better. 
  
TECHNIQUE 
Requirements: two (or more) clean glass slides, fixative (95%ethyl alcohol, 
formalin, acetic acid), lead pencil, test request form, and staining.  
Application of diagnostic techniques such as cytomorphometry, DNA 
cytometry, molecular analyses and toluidine blue staining techniques and 
also application of sophisticated computer programs has changed the 
scenario and made the interpretation of findings far more reliable than earlier. 
 
 Conventionally wooden spatula scrapings of buccal mucosa were a 
favourite, but due to the pressure on the cells and folding and alteration of 
cytoplasm during smearing, a cytobrush is now a preferred device. 
 
Henry Sandler reviewed various other techniques which included cotton tip 
applicators, vigorous normal saline rinse, forceful aspiration of cells from 
the surface, aspiration of resting saliva from the floor, etc, and discussed the 
pros and cons of each. Ayre spatula is being used in cervical cytology.  
 
After gargling / cleaning  the lesion gently scrape the area of abnormality 
with a wooden tongue spatula. Remove one of the slides from the fixative 
and evenly smear the collected material on one of the slides. Immediately re 
immerses the slide in fixative. Repeat the process with the second slide if 
necessary for better diagnostic yield. Repeat the process for additional areas 
if necessary. 
  
 
 
CYTOBRUSH 
 
 
The Cytobrush has been used frequently in cervical cytology, but as yet its 
value in oral exfoliative cytology has not been assessed. A study was 
undertaken to compare the efficiency of the Cytobrush with that of the 
wooden tongue spatula. 
 Cytobrush produced significantly better dispersion for the dorsal tongue, 
ventral tongue and buccal mucosa and a better cell yield for the tongue 
surfaces. No significant difference for cell yield or dispersion was found for 
the hard palate. The study showed that the Cytobrush is an effective 
instrument for use in exfoliative cytology of normal oral mucosa. 
 
Brushing is the favoured method for collecting many specimens. In the 
uterine cervix, the transformation zone, or squamocolumnar junction, is best 
sampled by a brush. Brushing of the oesophagus, stomach, lung or colon is 
commonly performed during endoscopic examination. Endoscopic brushing 
can specifically sample a visible lesion. A major pit fall in the evaluation of 
brush specimen is the risk of misinterpretation of a sample as abnormal, 
simply because many cells are present. Although, brushing techniques 
characteristically recovered large numbers of cells, that time itself does not 
indicate that the sample is malignant. Cells morphologic features of 
malignancy must be present.  
 
 
  
 
Oral cells can be obtained by different physical systems of scraping the 
surface of the mucosa, by rinsing the oral cavity or even by taking a sample 
of saliva from the patients. The reliability of the different instruments used 
in oral exfoliative cytology has been reviewed in different studies.  
The ideal instrument used for making a good cytological smear should be 
easy to use in any location, cause minimum trauma and provide an adequate 
and representative number of epithelial cells. It has been shown that a brush 
is an adequate instrument due to its ease in sampling and to the quality of the 
oral cytologic sample.  
Brush biopsy is a simple, relatively inexpensive, high sensitive, risk-free 
method of screening for cancer and serves as an aid to the clinical 
examination. The improved accuracy is attributed to the ease in obtaining 
full transepithelial cellular samples and the evaluation of smears with an 
image analysis system that has been adapted specifically to detect oral 
epithelial abnormalities by some workers. Full-thickness sampling (indicated 
by pinpoint bleeding during procedure is essential if histomorphological, 
evaluation of the collected cells is to yield representative findings. For 
example, many dysplastic lesions are first identified in the basal epithelial 
layers, and the diagnostic histomorphological findings may be lost as the 
cells mature and parakeratin and keratin are produced. To the classical 
applications of the oral cytologic studies, such as oral candidiasis, others 
have been added, such as studying the epithelial infection due to Epstein-
Barr virus in oral lesions of hairy leukoplakia, widening its possibilities. 
The importance of brush biopsy has been recently emphasized in a 
multicenter study where nearly 5% of clinically benign-appearing mucosal 
lesions were sampled by this technique and later confirmed by typical 
scalpel biopsy to represent dysplastic epithelial changes or invasive cancer. 
Other authors have also demonstrated the ability of the brush biopsy to 
uncover similar type lesions that were not clinically suspicious for 
carcinoma or preinvasive disease. There are controversies related to the real 
value of this technique in the early detection of OSCC. The existence of 
false positives has been pointed out showing high sensitivity (90%) and low 
specificity (3%). Nevertheless, these data have been discussed previously. 
 In a recent study by Potter et al., four false negatives of a total 115 analysed 
cases were found. Although the number of false positive cases is small it is 
important to emphasize that the mean delay time in diagnosing a carcinoma 
in these cases was of 117.25 days. However, more independent studies 
analysing its true validity and reliability as well as its applicability and its 
comparison with other techniques are necessary.  
Multiple studies with different results have been carried out, analysing the 
application of the cytology in the detection of dysplastic lesions. In a study 
from Sudan, oral scrape smear cytological analysis has been proposed as a 
useful early diagnostic method for epithelial atypia and therefore also for 
malignant oral lesions .Despite the improvements in the methods used for 
collecting oral cytological material this methodology still presents problems 
in diagnosing oral cancer. Problems are mainly due to the existence of false 
negatives obtained as a result of a non representative sample as well as the 
subjectivity of the cytologic evaluation. 
 RECENT ADVANCES 
 
1. Liquid-based-cytology 
2. Cytomorphometric analysis 
 
 
 
LIQUID BASED CYTOLOGY 
 
 
The liquid based cytology (LBC) corresponds to a sampling where cells are 
put in liquid suspension. For the clinician, the sample is made the same 
manner as that of the conventional smear by using a plastic brush, which can 
take the squamo-columnar junction and the endocervix, or by combining the 
use of a spatula and an endocervical brush. The taken material is then 
immediately rinsed in the bottle, which contains a fixative allowing transport 
to the laboratory. A part of the sizable brush can be left in the bottle. The 
clinician does not have to deal with any spreading, which is done at the 
laboratory.  
 
Currently two technical methods, which use automats, were validated by 
Food and Drug Administration (FDA) and are used frequently. One is 
proceeding by filtration and collecting cells vacuum-packed on a membrane 
with transferring cells on a glass (ThinPrep®, Cytyc®). The other is 
proceeding by centrifugation and sedimentation through a gradient of 
density (Surepath®, Tripath Imaging®). Cytoscreen System® (SEROA®), 
Turbitec® (Labonord®), CellSlide® (Menarini®) and Papspin® 
(Shandon®) technics are centrifugation and sedimentation manual 
techniques, which do not use automate and do not require a FDA agreement. 
They become established in Europe since 2003.  
 
Spreading out in thin layer which results from these techniques eliminates a 
great part of the inflammatory cells, necrosis and of red blood cells, outcome 
to "a cleaning" of spreading out. The LBC makes it possible to avoid the 
majority of the artefacts of superposition of the conventional smear but the 
dispersion of the cellular material removes also usual visual reference marks. 
The cytologists are used to reading smears fixed in a liquid for the urines, 
the serosa or the ovaries. It imposes an analysis element by element and a 
training at least 6 months to readjust the morphological criteria. The cells are 
not flattened on the support but deposited and the pictorial aspects are some 
modified. The nuclei are not hyper chromatic any more but take a vesicular 
aspect. The cytoplasms are important to differentiate the cellular origin. 
 
APPLICATION OF TECHNIQUES 
RESPONSE TO RADIATION THERAPY 
Radiotherapy is frequently used as a standard treatment for locally advanced 
carcinoma of oral cavity. Although the response of malignant tumours and 
surrounding normal tissue to various doses of ionizing radiation is generally 
predictable, variability in the host-tumour reaction in a specific individual 
makes the response unpredictable.  
 
The cytological evaluation of sequential oral smears during radiation therapy 
presents a unique opportunity to study the radiation response of oral 
malignant tumours. Earlier reports have described various cytoplasmic and 
nuclear changes in a variety of malignant cells evaluated by cytology after 
radiation therapy and included cellular enlargement, vacuolization, 
cytoplasmic granulation, nuclear enlargement, pyknosis, karyorrhexis, 
karyolysis, multinucleation, micronucleation, nuclear budding and 
binucleation Later on micronucleation was accepted as a reliable indicator 
for monitoring the effectiveness of chemopreventive agents against cancer 
and for monitoring the toxicity of chemicals. In a study comparing the post-
radiation changes in normal and malignant oral cells it was found that 
various morphological abnormalities demonstrated a consistent significant 
increase with radiation dose.  
 
Scotland was the first European country to integrate LBC in an organized 
screening program.  This decision was made on the results of a study of 70 
000 smears concerning 3 centres. Cost efficiency calculation was for the 
benefit of LBC because the rate of inadequate smears passed from 7 % with 
the conventional smear to 1 % with the smear in liquid medium. 
The definition of an inadequate smear in Scotland and England includes the 
smears deprived of endocervical cells. This definition explains the high 
percentage of inadequate cells. In the pilot study made in England, the rate 
of definite inadequate smear according to criteria's of the National Health 
System Cervical Screening Programs (NHSCSP) is from 
9.1 % with the conventional smear to 1.6 % with LBC. 
 
It was concluded that no evidence is available to claim higher accuracy of 
LBC to predict histologically confirmed CIN2+, but recognized that LBC 
improves the quality and speed of interpretation, and offers the possibility of 
additional molecular testing. 
Therefore both CP and LBC for screening in Europe are recommended. 
Preferences should be determined depending on local economical 
considerations. 
 
 CYTOMORPHOMETRIC ANALYSIS 
 
Ogden et al. suggested that quantitative techniques, based on the evaluation 
of parameters such as nuclear area (NA), cytoplasmic area (CA), and 
nucleus-to-cytoplasm area ratio (NA/CA), may increase the sensitivity of 
exfoliative cytology for early diagnosis of oral cancers, since these 
techniques are precise, objective and reproducible. Cowpe et al. 
demonstrated that exfoliative cytology is capable of detecting malignant 
changes, through estimation of NA/CA using the planimeter method in 
Papanicolaou-stained smears.  
 
This study, published in 1985, concluded that 50 cells were sufficient to 
provide indication of malignant changes. Since then, a number of studies 
have been carried out using the technique described by these authors to 
evaluate the influence of diverse systemic and external factors on NA, CA 
and NA/CA. In these studies planimeters have been replaced by 
semiautomatic image analysis techniques, which are faster, more accurate 
and more reproducible.  
 
Cowpe et al. found that tissues undergoing malignant transformation 
typically show a reduction in CA before the reduction in NA. They also 
suggested that samples of healthy mucosa from the same patient provide the 
best control. Ramaesh et al. used cytomorphometric techniques to assess 
nuclear diameter (ND) and cytoplasmic diameter (CD) in normal oral 
mucosa, in dysplastic lesions and in squamous cell carcinomas. They found 
that CD was highest in normal mucosa, lower in dysplastic lesions, and 
lowest in SCCs. By contrast, ND was lowest in normal mucosa, higher in 
dysplastic lesions, and highest in SCCs.  
 
These studies suggested that reduced nuclear size and increased cytoplasm 
size are useful early indicators of malignant transformation, and thus 
exfoliative cytology is of value for monitoring clinically suspect lesions and 
for early detection of malignancy. 
 
Nuclear DNA content and DNA-image cytometry Static cytometry permits 
the quantification of DNA content in cells obtained by exfoliative cytology. 
However, routine Haematoxylin-Eosin staining is inadequate for this 
purpose, and special techniques are required to ensure that staining intensity 
is in proportion to DNA content. The Feulgen reaction meets this criterion, 
since it is a stoichiometric procedure: in other words, each fixed molecule of 
Schiff's reagent corresponds to a constant and equivalent portion of the DNA 
molecule. The advantage of this procedure is that staining intensities (and 
thus DNA contents) can be determined automatically by spectrophotometry 
or densitometry as well as digital image analysis.  
 
Using cytology and DNA-image cytometry, it is easy to prove that oral 
lesions with the diagnosis of lichen planus and other inflammatory diseases 
show no suspicious cells. A recent review of literature places the rate of 
malignant transformation of lichen planus to squamous cell carcinoma at 
0.2%. On the contrary, the presence of malignant cells was demonstrated in 
one of 21 cases with leukoplakia (4.76%), in all cases with erythroplakia and 
in all squamous cell carcinomas.  
 
A meta-analysis of 2236 cases of leukoplakia from five studies has revealed 
a range of malignant transformation of leukoplakia between 2.2 and 17.5%. 
Furthermore, Sciubba, Silverman et al. and Mashberg et al. emphasized the 
fact that erythroplakia, occurring as either an isolated lesion or as a 
component of leukoplakia (erythroleukoplakia) is a marker of severe 
epithelial dysplasia or carcinoma in situ. In fact, 90% of erythroplakia were 
histologically diagnosed as in situ or invasive carcinomas. In one study, it 
was shown that sensitivity of cytological diagnosis combined with DNA-
image cytometry may reach 100%, whereas specificity was 97.4%. The 
authors reported a case of erythroplakia in which intraobserver variability 
among four pathologists led to diagnoses ranging from mild to severe 
dysplasia and because of the cytological and DNA cytometric diagnosis 
(severe dysplasia with DNA aneuploidy), this case was finally diagnosed on 
early cytological and DNA-cytometric diagnosis prior to the histological 
diagnosis.  
 
Remmerbach et al have reported that sensitivity of cytological diagnosis 
combined with DNA-image cytometry was 98.2% and specificity 100%, 
when compared with the gold standard' of histology. In a study, Maraki et al. 
analyzed 150 patients with histologically proven epithelial dysplasia of 
which 36 developed squamous cell carcinoma. DNA-cytometry showed 
DNA-diploidy in 105 patients. 20 patients had DNA-polyploidy and in 25 
patients DNA-aneuploidy was found at the time of the initial diagnosis.  
 
Carcinoma developed in only three of the 105 diploid lesions when 
compared with 21 of the 25 aneuploid lesions. Remmerbach et al. concluded 
in the clinical setting that DNA-aneuploidy might detect histologically 
obvious malignancy, 1-15 months prior to histology. Sudbo et al. analyzed 
archival material and reported that the nuclear DNA-content in cells of oral 
leukoplakia may be used to predict the risk of oral epithelial dysplasia up to 
5 years before histological diagnosis. Based on these observations, they 
proposed brush biopsies with cytological/DNA-cytometric examination for 
microscopic evaluation of white or red patches of the oral cavity 
(leukoplakia or erythroplakia). 
 
Cytomorphometric analysis is useful in differentiating dysplastic and 
malignant squamous cells from normal squamous cell, discriminant analysis 
based on ND and CD values further increases the sensitivity and specificity. 
 
Sensitivity; 89%,  
Specificity; 89.7%,  
Positive predictive value; 80% 
Negative predictive value; 94.4%  
 
Sensitivity of  cytological diagnosis on oral smears for the detection of 
cancer cells was 95,0%, specificity 99,6%, positive predictive value 98,3% 
and negative predictive value 99,8%. On this basis the prevalence of DNA-
aneuploidy in smears of oral squamous cell carcinomas in situ or invasive 
carcinomas was 96.6%. Sensitivity of DNA-aneuploidy in oral smears for 
the detection of cancer cells was 96,6%, specificity 100%, positive 
predictive value 100% and negative 99,2%. The combination of both 
techniques increased the sensivity to 98.3%, specificity to 100%, positive 
predictive value to 100% and negative to 99.6%. 
 
 
  
 
 CYTOLOGY DNA-
CYTOMETRY
 COMBINED 
DNA-
CYTOMETRY 
AND 
CYTOLOGY 
SENSITIVITY 95.0% 96.5% 98.3% 
SPECIFICITY 99.6% 100% 100% 
POSITIVE 
PREDECTIVE 
VALUE 
98.3% 100% 100% 
NEGATIVE 
PREDECTIVE 
VALUE 
99.8% 99.2% 99.6% 
 
 
cInstitute of Cytopathology, Heinrich Heine University, Moorenstraße 5, D-
40225 DüsseldorfScrape.  
 
RECENT  APPLICATION: 
A quick browsing through the search engines reveals that a number of 
special procedure can be performed on exfoliated cells like IHC, ICC, PCR., 
flow cytometry, image analysis, neural networking, interphase cytogenetics, 
southern blotting, special staining for infections, ISH,…. the list is long and 
never ending and demonstrates the scope of this branch in disease diagnosis. 
 
 
PROLIFERATION INDEX AND AgNOR ANALYSIS 
 
The Ki-67 antibody was first developed by Gerdes and coworkers, who 
demonstrated the antigen to be present in G1, S, G2 and M phases of 
continuously cycling cells, but absent in G0 cells. Since then, its utility as a 
proliferative marker for both diagnostic and research purposes has increased 
progressively. To the best of our knowledge there are no previous 
publications on the application of Ki-67 immunostaining to oral scrape 
smears even though histologic material from the oral cavity and 
cytologic smears from the uterine cervix have been extensively studied. 
 
A pilot study conducted by Prashant Sharma (Departments of Pathology and 
Radiotherapy, Maulana Azad Medical College and associated Lok Nayak 
Hospital, New Delhi 2) , was carried out as a part of a larger project to study 
the feasibility of oral cytology in predicting response to radiotherapy. Cancer 
of the head and neck is amongst the commonest malignancies presenting to 
radiotherapy clinics in India, and the demand for economically viable and 
technically feasible prognostic tests is therefore intense 
The comparatively much lower expression of Ki-67 in oral cytologic smears 
may have multiple reasons, the most obvious of which is the overall low 
yield of malignant cells in scrape smears. This has also been observed by 
other researchers Umiker et al for instance, found in an early series of 55 
cases that scrapes from half the patients had 25% or less morphologically 
malignant cells. An additional reason could be that the Ki-67 labelling 
indices at the deep invasive fronts of tumours are higher than those at the 
centre or surface of mucosal cancers. 
 
This indicates that actively proliferating cells are concentrated at the deep 
tumour margin, an area that obviously cannot be sampled by the superficial 
oral scrape. And finally, obscuring inflammation and blood, necrotic or 
proteinaceous debris and bacterial contamination often hamper cytologic 
evaluation in these smears, a limitation that may be surmountable by the use 
of liquid based cytology. 
 
Prior histologic studies on oral SCC have documented a radiation induced 
decline in the number of proliferating cells. The complete absence of any 
positive cells in our post therapy smears appears to corroborate this. 
However, it needs to borne in mind that the overall cellularity and especially 
the yield of malignant or dysplastic cells in the post-24 Gray smears was 
extremely low. 
The few bizarre radiation altered cells that were present in these post-
treatment smears have been considered to be genetically damaged and hence 
mitotically inactive cells by Bhattathiri et al. 
  
In conclusion, Ki-67 expression is low in scrape smears from oral SCC. 
Considering that nearly 77% (33 out of 43) cases had a labelling index of 
zero even pretreatment and all positive ones were in the range of 0.1 to 
0.01% indicates that Ki-67 immunostaining on conventional oral scrape 
cytology, though previously unreported in literature, is probably not the 
optimal tool for evaluation of proliferative status of oral squamous cell 
cancer. 
 MOLECULAR ANALYSIS 
Nowadays cancer is considered as a process caused by the accumulation of 
multiple genetic alterations, which affect the cell cycle as well as normal cell 
differentiation. These alterations are mainly acquired (somatic) although 
some of them may be inherited and when they activate protooncogenes, 
inactivate tumour suppressor genes or affect enzymes, which repair DNA, 
they could lead to a neoplasic transformation. 
Most of the oral cavity carcinogens are chemical (tobacco), physical 
(radiation) and infectious (papillomavirus, Candida) agents which act as 
mutagens and may cause changes in genes and chromosomes structures by 
point mutations, deletions, insertions and rearrangements However, some of 
these changes may occur spontaneously. These genetic alterations, which 
occur during carcinogenesis, can be used as targets for detecting tumoral 
cells in clinical samples  
Molecular analysis can identify a clone population of cancerous cells that 
have tumour specific point mutations among normal cells. 
Mutations in the tumour suppressor gene p53 are the most frequent genetic 
alterations in human cancer and show a variable frequency in oral cancer 
several authors have studied and in some cases demonstrated the potential 
clinical application of oral cytology for detecting point mutations in p53 as a 
specific neoplastic marker in OSCC. However, some authors consider that 
the high number of point mutations, which can be found in p53, limits its 
potential clinical application in cost-effective early detection of oral cancer. 
The applicability of other molecular markers such as epigenetic alterations 
(hypermethylation of promoter regions) and the genomic instability such as 
loss of heterozygosity (LOH) and microsatellite instability (MSI) has also 
been studied. 
EPIGENETIC ALTERATIONS, LOSS OF HETROZYGOSITY AND 
MICROSATELLITE INSTABILITY 
The main epigenetic modification in tumours is methylation and it seems 
that the changes in the methylation patterns can play an important role in 
tumourogenesis. These epigenetic alterations are often associated with the 
loss of genetic expression and their occurrence seems to be essential for the 
multiple necessary genetic events. So tumoral progression takes place 
because these alterations can inactivate DNA repairing genes. The 
hypermethylation of CpG islands, which are usually unmethylated, in 
promoter regions, is correlated with the loss of gene expression.  
Rosas et al. studied the methylation patterns of p16, MGMT and DAP-K 
genes in carcinomas and smears of patients suffering head and neck cancer. 
They detected abnormal hypermethylation patterns in both kinds of samples 
by a methylation specific PCR. That is why they proposed that this 
technique allows a sensitive and efficient detection of tumoral DNA and it is 
potentially useful for detecting and monitoring recurrences in these patients. 
Usually the genetic instability is determined by LOH, which reflects an 
allelic loss in the genomic region where the locus marker stands, as well as 
by MSI, which implies a change in the length of the microsatellite loci. 
Several studies have demonstrated by using microsatellite markers that 
alterations in certain regions of chromosomes 3p, 9p, 17p and 18q are 
associated with the development of head and neck squamous cell carcinomas.  
Microsatellite regions are distributed along the genome and have been 
widely and satisfactorily used as molecular markers for carcinogenesis. 
Alterations in these regions have been used as clonal markers and for 
detecting tumoral cells among normal cells. Analysis of these regions can 
reveal LOH or MSI in the studied region. 
Several authors have evaluated the analysis of microsatellite loci (LOH and 
MSI) in oral cytologic samples and tumoral tissue. They observed that the 
profile of changes produced in the tumoral tissue was similar to the one 
observed in the cytologic samples. They reached the conclusion that this 
kind of analysis allows the detection of DNA from tumoral cells of the 
cytologic samples. Spafford et al. also pointed out that when trying to detect 
tumoral cells among normal cells in oral cytologic samples markers used for 
studying MSI were more efficient that the ones used for LOH. The 
applications of oral cytologic molecular studies in oral precancer have been 
minimally studied may be due to the difficulty in obtaining representative 
material of these lesions. 
Applying the brush biopsy methodology, apoptotic biomarkers in cells 
obtained by displasic leukoplakias and lichen planus have been analysed. It 
is important to remark that apoptotic cells present the same morphology than 
non-apoptotic. That is why it is important to apply these techniques to 
differentiate them. In this study a high percentage of apoptotic cells in 
patients with leukoplakia or lichen planus have been demonstrated. 
 
In a recent study another controversial aspect such as the infection by human 
papillomavirus (HPV) has been investigated in patients with proliferative 
verrucous leukoplakia comparing them with patients with simple 
leukoplakia using for this purpose cytologic analysis of oral cells. The 
results show no representative differences in the detection between both 
groups of HPV DNA. 
In conclusion we can point out that oral cytology is re-emerging as a 
diagnostic tool in oral precancer and cancer as the result of applying new 
physical as well as molecular methodological techniques. 
 
 
 
 
NUCLEAR DNA CONTENT AND DNA-IMAGE CYTOMETRY 
 
Static cytometry permits the quantification of DNA content in cells obtained 
by exfoliative cytology. However, routine Haematoxylin-Eosin staining is 
inadequate for this purpose, and special techniques are required to ensure 
that staining intensity is in proportion to DNA content. The Feulgen reaction 
meets this criterion, since it is a stoichiometric procedure: in other words, 
each fixed molecule of Schiff's reagent corresponds to a constant and 
equivalent portion of the DNA molecule. The advantage of this procedure is 
that staining intensities (and thus DNA contents) can be determined 
automatically by spectrophotometry or densitometry as well as digital image 
analysis.  
 
IMMUNOHISTOCHEMICAL IDENTIFICATION OF TUMOUR 
MARKERS 
 
The identification of tumoral markers, notably cytokeratins in smears from 
the oral cavity has attracted considerable interest. Cytokeratin expression 
profile provides useful information on cell differentiation status but its 
potential for early diagnosis of oral cancer is limited. However, certain 
cytokeratins, such as K8 and K19 are useful if not definitive indicators of 
malignancy, particularly if their presence is interpreted in conjunction with 
other information, such as DNA profile.  
 PCR/MICROFLUOROMETRY 
Cervical cancer screening is conducted by a cytological Papanicolaou (Pap) 
test. For screening, it is becoming increasingly important to introduce a more 
objective result, based on human papillomavirus (HPV) DNA test. We 
describe here a practical method allowing the mass detection of HPV-DNA 
by PCR followed by fluorogenic DNA intercalation using cervical scrapes or 
biopsy specimens obtained from women who had undergone cytological 
testing for cervical cancer. Crude DNAs were extracted by a simplified 
proteinase K-boil method. Common and type-specific primers were newly 
designed for major types of high-risk HPVs. A fluorogenic DNA intercalator, 
SYBR® Green I was directly added to the specific PCR products. The 
resultant fluorescence was measured by a conventional fluorometric 
microplate reader. Results: The proposed PCR/microfluorometry (MFL) 
allowed a simple, rapid and economical detection of HPV-DNA without any 
use of labelling primers or probes. HPV-DNAs were found in 48.2% 
(123/255) of the cervical scrapes. The detection rate of HPV in cervical 
cancer biopsy specimen was 92.4% (61/66). Conclusions: PCR/MFL 
detection of HPV-DNA, followed by combined type-specific PCR, is 
expected to be an extremely useful tool in cervical cancer 
screening.( Department of Pathology, Sapporo Medical University, Japan.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIAL AND METHODS   
 A prospective study of 207 cases of mucocutaneous malignancies for 
comparative study of scrape cytology and biopsy were taken both as an 
outpatient and inpatient in the department of surgical oncology Government 
Royapettah Hospital in the period between July 2006 and May 2009. Out of 
207 cases, Head and Neck cancers were 125 cases both primary and follow-
up cases, cervical cancers were 53 both primary and follow-up cases, skin 
cancers were 21 both primary and follow-up cases, penile cancer 7 and anal 
canal cancer 1. Type of lesions such as proliferative, ulcerative, infiltrative 
and verrucous lesions and also presence or absence of infections was 
assessed clinically.  
 
NEW CASES 
 
TYPE OF MUCOCUTANIOUS 
CANCER 
TOTAL NUMBER 
OF CASES 
HEAD AND NECK CANCER 
( Tongue, Buccal mucosa, Alveolus, Palate, Lip) 
98 
LOWER GENITO URINARY CANCER 
(Vulva, Vagina, Cervix) 
44 
SKIN CANCER 19 
ANAL CANAL 1 
PENIS 7 
  
FOLLOW UP CASES 
 
 
TYPE OF MUCOCUTANIOUS 
CANCER 
TOTAL NUMBER 
OF CASES 
HEAD AND NECK CANCER 
( Tongue, Buccal mucosa, Alveolus, Palate, Lip) 
27 
LOWER GENITO URINARY CANCER 
(Vulva, Vagina, Cervix) 
9 
SKIN CANCER 2 
ANAL CANAL 0 
PENIS 0 
 
 
 
PREPARATION 
 
For all cases before proceeding for scraping, advised gargling in case of oral 
cancer \ Cleaning in other mucocutaneous lesion. Biopsies were done in all 
cases simultaneously following scraping. 
 
 
REQUIREMENTS FOR THE STUDY AS FOLLOWS 
 
Two (or more) clean glass slides  
Fixative (95% ethyl alcohol), formalin, acetic acid  
Scraping spatula 
Lead pencil 
Test request form 
Staining 
 
TECHNIQUE 
 
After cleaning the lesion, the lesion was scraped gently with a wooden 
tongue spatula or ayres spatula in the case of cervical cancer. 
Evenly smeared the collected material on one of the glass slide, air dried or 
immediately immersed the slide in fixative. In our study we use both dry and 
wet preparations and repeated the process with the second slide in case of 
verrucous growth or post radiation follow up cases, if necessary for better 
diagnostic yield. In our study we repeated the process in few cases. Labelled 
the slides with lead pencil and placed in a container filled with 95% ethyl 
alcoho 
  
STAINING PROCEDURE: 
All slides were stained in pathology laboratory by following the steps given 
below. 
 
Fix smear in 10% neutral buffered formalin at the room temperature for 20 
seconds. 
Rinse in tap water. 
Stain in harris’s (progressive) hematoxylin for 1 min. 
Wash well in tap water for 10 – 20 sec,.  
Stain in 1% aqueous eosin for 10 sec,. 
Rinse in tap water. 
Dehydrate, clear and mount. 
All slides were reported by single pathologist on the same day.  
 
 
 
 
 
                 RESULTS AND OBSERVATION 
RESULTS 
Out of 207 cases of scrape cytology true positive cases were 133 cases, true 
negative cytology were 56 cases, false positive cytology were 7 cases, false 
negative cytology 11 cases as depicted in the tabular column and in the bar 
diagram 
RESULTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 BIOPSY  
CYTOLOGY +VE - VE TOTAL 
+VE 133 7 140 
-VE 56 11 67 
TOTAL 189 18 207 
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From the above results Sensitivity, specificity, accuracy, positive predictive 
value, negative predictive value are calculated using the formula below, 
 
Sensitivity = TP/ TP + FN  
Specificity = TN/ TN + FP 
Positive predictive value = TP / TP + FP 
Negative predictive value = TN / TN + FN 
Accuracy (A) = TP + TN / TP + FP + TN + FN  
 
OVERALL RESULT 
 
True Positive:   133 
 
False Positive:  7 (Post radiation Lesions) 
 
 False Negative: 56 
 
 True Negative: 11. 
 Sensitivity 70.3%, 
 
Specificity 61.1% 
 
Accuracy 69.5% 
 
Predictive value of positive cytology; 94.8% 
 
Predictive value of negative cytology; 16.9% 
 
Sensitivity of cytological diagnosis on oral smears for the detection of 
cancer cells in different studies were 95,0%, specificity 99,6%, positive 
predictive value 98,3% and negative predictive value 99,8%. In various 
studies Scrape cytology sensitivity and specificity were 26% and 97%, 
respectively in cervical lesion. (Eftekhar etal) 
 
METHODS TO INCREASE SENSITIVITY & SPECIFICITY: 
 
QUANTITATIVE ANALYSIS: 
Sensitivity and specificity of cytology can be increased by  quantitative 
cytomorphometric analysis which is useful in differentiating dysplastic and 
malignant squamous cells from normal squamous cell 
Discriminant analysis based on ND and CD values increases sensitivity from 
conventional technique .A comparative study at Institute of Cytopathology, 
Heinrich Heine University, Moorenstraße .compared conventional cytology, 
DNA-cytometry and combining both increases the  
 
Sensitivity by 98.3% 
Specificity by 100% 
Positive predictive value by100% 
Negative predictive value by 99.6% 
 
LIQUID-BASED CYTOLOGY: 
 
Since liquid-based cytology was developed in the 1990s various comparative 
studies have shown that it can offer significant advantages over conventional 
exfoliative cytology. In cervical uterine cancer screening, the liquid-based 
preparations have also demonstrated a significant reduction in false-negative 
rates as compared with those of conventional smears In a recent study from 
Brazil the liquid-based preparations resulted in higher specimen resolution 
as well as presenting a better cytological morphology for, squamous cell 
carcinomas, 
 
Liquid-based cytology has been developed as an alternative and has been 
reported to increase the sensitivity of smear tests and decrease the proportion 
of slides that are unsatisfactory for assessment. 
 
In the pilot study made in England, the rate of definite inadequate smear 
according to criteria's of the National Health System Cervical Screening 
Programs (NHSCSP) is from 9.1 % with the conventional smear to 1.6 % 
with LBC. 
 
CYTO BRUSH 
 
Cytobrush is an effective instrument for use in exfoliative cytology to collect 
cells.  Its advantages are it avoids pressure on the cells, avoids folding, and 
alteration of cytoplasm during smearing.Hence cytobrush is now a preferred 
device for cell collection. 
 
STAINIG & SLIDE PREPARATION 
 
 The advent of techniques like Toluidine blue staining, brush biopsy and 
application of sophisticated computer programs has changed the scenario 
and made the interpretation of findings far more reliable than earlier. 
 
Currently, two technical methods, which use automats, were validated by 
Food and Drug Administration (FDA) and are used frequently. One is 
proceeding by filtration and collecting cells vacuum-packed on a membrane 
with transferring cells on a glass (ThinPrep®, Cytyc®). The other is 
proceeding by centrifugation and sedimentation through a gradient of 
density (Surepath®, Tripath Imaging®). Cytoscreen System® (SEROA®), 
Turbitec® (Labonord®), CellSlide® (Menarini®) and Papspin® 
(Shandon®) techniques are centrifugation and sedimentation manual 
techniques, which do not use automate and do not require a FDA agreement. 
 
In our study we followed conventional techniques such as wooden spatula 
for scraping, air dry or wet slide preparation, heamatoxilin and eosin staining 
with conventional microscope for cytophalogical study. Hence sensitivity 
(70.3%), specificity (60.1%) which is low when compared to the other 
international studies. 
 
 In our study false positive cases were 7, these false positive cases were all 
post radiation follow up cases. Scrape cytology was positive for malignancy 
and biopsy was negative for malignancy. Hence, we repeated scrape 
cytology second time, which was reported as negative for malignancy. We 
concluded that initial positive slide was due to radiation induced decline in 
proliferative cell and misinterpretation of nuclear changes as positive. We 
kept all these cases under regular follow up 
 
56 slides were reported as false negative, the reasons could be  
 Low concentration of proliferating cells on the surface of the lesion which is 
due to the following reasons, 
Infection (bacterial colonies, inflammatory cells) 
Anucleate squames, 
Proteinaceous material, 
Verrucous carcinoma, 
Infiltrative lesion, 
Radiation induced decline in proliferation. 
Out of 207 cases, 189 cases were positive in biopsy, 18 cases were negative 
this could be due to biopsy from non-representative areas and              
inadequate sampling. More over us have not compared biopsy with final 
histopathology report. 
 
In our study we emphazise that patients with trismus and posterior 1/3 
tongue lesions and patients who refuses biopsy, scrape cytology is a more 
useful technique for rapid diagnosis when compared to biopsy which may 
need hospitalisation and anaesthesia. 
 
 
 
 
 
 
 
 
 
 
 
 CONCLUSION 
 
Biopsy is the Gold Standard procedure for the diagnosis of mucocutaneous 
malignancies. 
Scrape (exfoliative) cytology is a simple and noninvasive procedure, which 
has been a controversial technique according to its real validity. In recent 
times it has re-emerged due to its application in mucocutaneous cancer as a 
diagnostic and predictive method as well as for monitoring patients. 
Rationale of exfoliative cytology lies in loss of cohesiveness of cells, 
proliferating cells and proplastic cells (Cell with an increased activity). 
 
The results of the current study demonstrate that scrape cytology is a  
reliable rapid screening and diagnostic procedure in the outpatient setting for 
mucocutaneous malignancy. The duration of the scrape cytology process 
takes 20 min as against 3 to 4 days for biopsy.  
 It is a painless, bloodless noninvasive, quick and simple procedure. 
 
In our study the Sensitivity is 70.3% and   positive predictive value is 94.8% 
as against 95% and 98% respectively in other studies. Positive scrape 
cytology is reliable for clinical decision making, but negative scrape needs 
confirmation by biopsy. Scrape cytology is not reliable in follow up cases, 
especially in post RT situations. In our study false positive cases were 7, 
these false positive cases were all post radiation follow up cases. We 
concluded that positive slides were due to radiation induced decline in 
proliferative cell and misinterpretation of nuclear changes as positive. 
In our observation from this study scrape cytology is more sensitive in 
proliferative and ulcerative lesions and less sensitive in infiltrative and 
verrucous lesion due to less number of proliferative cells and keratinisation.    
 
Scrape is not an alternative to biopsy.   
Scrape cytology guards against false negative biopsy. 
In posterior 1/3 tongue lesion, oral cancer patients with trismus and in 
patients who refuses biopsy, scrape cytology is useful. 
 
In our study it is clear that the Sensitivity and specificity can be further 
improved by application of newer techniques such as Cytobrush, liquid 
based cytology, Cytomorphometric analysis and by trained Cytopathologist, 
thereby making this cytological technique as a more reliable diagnostic and 
predictive method as well as for monitoring patients. 
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PROFORMA 
COMPARATIVE STUDY OF SCRAPE CYTOLOGY AND BIOPSY 
IN MUCO CUTANEOUS MALIGNANCY 
 
S. No.:                                                                                               IP 
No.: 
Name;                                                                                               CD 
No.: 
Age;                                                                                                  Date: 
Sex M/F                                
Scrape 
Occupation:                                                                                      
Cytology No: 
Address:                                                                                            
Biopsy No.: 
                                                                                                       1. 
Punch biopsy     
                                                                                                      2. 
Wedge Biopsy 
 
 
DIAGNOSIS: 
PRIMARY/RESIDUAL/RECURRENCE 
 
Staging: 
 
Site of Growth: 
 
Oral Cavity 
 
     Lip 
     Palate 
Buccal Mucosa 
 
Gingiva 
 
Tongue 
 
Floor of the Mouth 
 
 
Skin 
 
Genitals 
 
Female 
 
     Vulva 
 
     Vagina 
 
     Cervix 
 
Male: Penis 
 
Anus 
 
Size of Growth: 
 
Oral Cavity:     T1     T2     T3    T4 
 
Skin            :     T1     T2     T3    T4 
 
Genitals 
 
Female 
 
Vulva          :     T1     T2     T3    T4 
 
Vagina        :     T1     T2     T3    T4 
 
Cervix        :    IA1      IA2    IIA    IIB 
 
                         IIIA     IIIB  IVA   IVB 
 
 
Male Penis:     T1     T2     T3    T4 
 
Anus          :     T1     T2     T3    T4 
 
 
Type of Lesion 
 
Ulcerative                   : 
 
Proliferative Growth: 
 
Verrucous Lesion     : 
 
Infection                    Present                     Absent 
 
Oral Cavity              :     No     N1     N2a     N2b 
 
                                        N2c    N3 
 
Skin                          :     No      N1 
 
Genitals 
 
     Vulva                   :     N0     N1      
 
     Vagina                 :     N0     N1     N2 
 
     Cervix                  :     N0     N1      
 
     Male Penis           :     N0     N1     N2     N3 
 
Anus                        :     N0     N1     N2     N3 
 
Previous Treatment 
 
RT          : Yes or No 
 
MODE   :          EBRT 
 
                           Branchy Therapy 
 
                           EBRT+ Branchy Therapy 
 
Total Dose: 
 
Number of Fractions 
 
Dose per Fractions 
 
Treatment Break     :          Yes/No 
 
Chemo Therapy       :          Yes/No 
 
      
 
 
REPORT: 
 
Scrape Cytology: 
 
Punch Biopsy:     SCC                 1. Infiltrating Keratinising  
2. Infiltrating Non Keratinising 
SCC 
 
 
                              BCC 
 
                              MELANOMA 
 
                               OTHERS 
 
 
 
 
 
  
 
SCRAPE IN POSTERIOR 1/3 TONGUE LESION 
 
 
 
 
 
 
 
SCRAPE IN POSTERIOR 1/3 TONGUE LESION WITH TRISMUS 
 
 
 
 
 
   NORMAL SQUAMOUS CELL 
 
 
 
 
 
 
                                       SQUAMOUS CELL CA 
 
 SQUAMOUS CELL CA 
 
 
 
                                           SQUAMOUS CELL CA 
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